Yong Lin

13.9k citations

271 papers · 10.1k indexed · 3 hit papers · h-index 51

Impact in

Cancer Research top 0.5%
- NF-κB Signaling Pathways
Oncology top 0.5%
- Cancer-related Molecular Pathways

Papers in

Oncology 92
- Cancer Risks and Factors 19
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 14
Cancer Research 50
- NF-κB Signaling Pathways 18
- Cancer, Lipids, and Metabolism 14

Co-authors: Zheng-gang Liu Weichung Joe Shih Anne Devin Chung S. Yang Niyati Parekh Yolanda Rodríguez Elisa V. Bandera Michelle A. Kelliher
Journals: Journal of Clinical Oncology (20 papers)Annals of the Rheumatic Diseases (9 papers)Cancer Causes & Control (8 papers)Annals of Oncology (8 papers)Cancer Prevention Research (7 papers)
Partner nations: United States China Germany

In The Last Decade

Yong Lin

260 papers receiving 9.9k citations

Hit Papers

align trajectories log scale

Ultra-Processed Foods and Incident Cardiovascular Disease in the Framingham Offspring Study 2021 · 140 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of the American College of Cardiology
2017 Journal of Clinical Oncology
2016 PEDIATRICS

Peers

Countries citing papers authored by Yong Lin

Since Specialization

Citations

This map shows the geographic impact of Yong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Lin more than expected).

Fields of papers citing papers by Yong Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Lin. The network helps show where Yong Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yong Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yong Lin Line = papers co-authored together Yong Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	US military veterans’ perceived concordance with their providers regarding persistent physical symptoms prospectively predicts satisfaction with care and adherence to care plans Annals of Behavioral Medicine ·L. Alison Phillips, Chang Xiang-yang, 柳珠賢., Yong Lin, 周小妮, Justeen Hyde, Peter J. Bayley, Helena K. Chandler, Kathleen Hefferon, Susan L. Santos, Rachel Stewart, Drew A. Helmer, Lisa M. McAndrew	2025	1
2	Advancing the Development of Innovative Human Platelet-Derived Exosomes for Enhanced Therapeutic Applications Cytotherapy ·Yong Lin, Haishan Lin, Mingxian Huang, Kui Liu	2025	0
3	Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up JNCI Cancer Spectrum ·俊三新田, Jean A. McDougall, Yong Lin, Shou‐En Lu, Scott T. Walters, Dean P. Hobson, Antoinette M. Stroup, Lisa E. Paddock, Sherry Grumet, Deborah Toppmeyer, Anita Y. Kinney	2024	1
4	SiamSEA: Semantic-Aware Enhancement and Associative-Attention Dual-Modal Siamese Network for Robust RGBT Tracking IEEE Access ·Felipe da Costa Thadeu, Marina Sara, Zeynab Skandari, Yong Lin, Hemdani Rahendra Herlianto	2024	0
5	Association of Cigarette Smoking and Alcohol Consumption With Subsequent Mortality Among Black Breast Cancer Survivors in New Jersey JAMA Network Open ·Nur Zeinomar, Bo Qin, S. Niggol Seo, Yong Lin, I. W Roxburgh, Jeanne M. Brett, Coral Omene, Karen Pawlish, Kitaw Demissie, Christine B. Ambrosone, Chi‐Chen Hong, Elisa V. Bandera	2023	8
6	Venous thromboembolism and acute myeloid leukemia: risk factors and mortality in elderly white, black and Asian patients Blood Coagulation & Fibrinolysis ·Ambarina S. Faiz, Shuang Guo, Ashwin Sridharan, Yong Lin, Claire S. Philipp	2023	5
7	Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow Journal of Clinical Oncology ·Anita Y. Kinney, Scott T. Walters, Yong Lin, Shou‐En Lu, 骆伟强, Yihui Wu, Dean P. Hobson, Rini Dwiyuna Ningsih, Denalee O’Malley, Antoinette M. Stroup, Lisa E. Paddock, Sherry Grumet, Tawny W. Boyce, Deborah Toppmeyer, Jean A. McDougall	2023	4
8	Associations of hair dye and relaxer use with breast tumor clinicopathologic features: Findings from the Women’s circle of Health Study Environmental Research ·J. Škorpíková, Jasmine A. McDonald, Emily S. Barrett, Patricia Greenberg, Salsabila Zahrah, Susanne Montgomery, Bo Qin, Yong Lin, Chi‐Chen Hong, Christine B. Ambrosone, Kitaw Demissie, Elisa V. Bandera, Adana A. M. Llanos	2021	18
9	Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA) Journal of Clinical Oncology ·J. Randolph Hecht, Sara Lonardi, Johanna C. Bendell, Hao‐Wen Sim, Teresa Macarulla, Charles D. Lopez, Eric Van Cutsem, Andrés J. Muñoz Martín, Joon Oh Park, Richard Greil, Hong Wang, Rebecca R. Hozak, Ivelina Gueorguieva, Yong Lin, Sujata Rao, Baek‐Yeol Ryoo	2021	78
10	Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer Cancer Medicine ·Xiang‐Lin Tan, E Jian‐Yu, Yong Lin, Timothy R. Rebbeck, Shou‐En Lu, Mingyi Shang, William Kevin Kelly, Anthony V. D’Amico, Mark N. Stein, Lanjing Zhang, Thomas L. Jang, Isaac Yi Kim, Kitaw Demissie, Anna C. Ferrari, Grace L. Lu‐Yao	2020	23
11	Predict multicategory causes of death in lung cancer patients using clinicopathologic factors Computers in Biology and Medicine ·Farming Magazine, Haijun Zhou, Yong Lin, J Heim, Lanlan Shen, Yuan Li, Lanjing Zhang	2020	17
12	Association of KRAS mutation with tumor deposit status and overall survival of colorectal cancer Cancer Causes & Control ·Meifang Zhang, Wenwei Hu, Kun Hu, Yong Lin, Zhaohui Feng, Jing‐Ping Yun, Nan Gao, Lanjing Zhang	2020	11
13	Biobehavioral effects of Tai Chi Qigong in men with prostate cancer: Study design of a three-arm randomized clinical trial Contemporary Clinical Trials Communications ·Anita Y. Kinney, Cindy K. Blair, Dolores D. Guest, Yihui Wu, Elizabeth Harding, Fabiano T. Amorim, Tawny W. Boyce, Lauren B. Hiller, C. Graham Ford, Matthew Schwartz, N. Essayem, P. Zandigiacomo, Jerry D. Gardner, Yong Lin, Wadih Arap, Michael R. Irwin	2019	13
14	Consumption of Sugars, Sugary Foods, and Sugary Beverages in Relation to Adiposity-Related Cancer Risk in the Framingham Offspring Cohort (1991–2013) Cancer Prevention Research ·Nour Makarem, Elisa V. Bandera, Yong Lin, Paul F. Jacques, Richard B. Hayes, Niyati Parekh	2018	58
15	Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary Carcinogenesis Cancer Prevention Research ·Soumyasri Das Gupta, Misaal Patel, J. Wahler, Min Ji Bak, B. Wall, Mao‐Jung Lee, Yong Lin, Weichung Joe Shih, Li Cai, Chung S. Yang, Nanjoo Suh	2017	11
16	Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study Cancer Epidemiology Biomarkers & Prevention ·E Jian‐Yu, Shou‐En Lu, Yong Lin, Judith M. Graber, David Rotter, Lanjing Zhang, Gloria M. Petersen, Kitaw Demissie, Grace L. Lu‐Yao, Xiang-Lin Tan	2017	26
17	Lack of pharmacokinetic drug–drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors Cancer Chemotherapy and Pharmacology ·Ding Wang, Fadi Braiteh, James J. Lee, Crystal S. Denlinger, Dale R. Shepard, Archana Chaudhary, Yong Lin, Ling Gao, Nicolas-Memmie Mogue, Federico Nasroulah, Patricia LoRusso	2016	2
18	Dose Finding Method in Joint Modeling of Efficacy and Safety Endpoints in Phase II Studies International Journal of Statistics and Probability ·Aiyang Tao, Yong Lin, José Cirı́aco Pinheiro, Weichung Joe Shih	2014	1
19	Inhibitory effect of voluntary running wheel exercise on the growth of human pancreatic Panc-1 and prostate PC-3 xenograft tumors in immunodeficient mice Oncology Reports ·Allan H. Conney, George C. Wagner, N. Mozola, Yong Lin, Weichung Joe Shih, Yue Liu, Xiaoxing Cui, Mou‐Tuan Huang, Xi Zheng	2008	38
20	A phase I and pharmacokinetic study of paclitaxel and carboplatin combined with sodium selenite in patients with gynecologic malignacies Cancer Research ·Murugesan Gounder, Darlene Gibbon, M.A. Ruiz-Ginés, Stan Ingersol, Brian Buckley, Morten B. Hofsøy, Yong Lin, Weichung Joe Shih, G Frenkel, Paula B. Caffrey, Eric H. Rubin, Stephen Zimmerbaum	2005	1

About Yong Lin

Yong Lin is a scholar working on Oncology, Cancer Research, Statistics and Probability, Hematology and Pathology and Forensic Medicine, having authored 271 papers that have together received 10.1k indexed citations. Recurring topics across this work include Cancer Risks and Factors (19 papers), NF-κB Signaling Pathways (18 papers), Rheumatoid Arthritis Research and Therapies (16 papers), Cancer Treatment and Pharmacology (15 papers), Statistical Methods in Clinical Trials (14 papers), Cell death mechanisms and regulation (14 papers), Cancer, Lipids, and Metabolism (14 papers) and Colorectal Cancer Treatments and Studies (14 papers). The work is most often cited by research in Cancer Research (2.4k citations), Oncology (3.1k citations), Immunology (1.6k citations), Biochemistry (430 citations) and Pulmonary and Respiratory Medicine (2.1k citations). Yong Lin has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Zheng-gang Liu, Weichung Joe Shih, Anne Devin, Chung S. Yang, Niyati Parekh, Yolanda Rodríguez, Elisa V. Bandera, Michelle A. Kelliher, Qingfeng Yang and Joseph Lewis. Their work appears in journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases, Cancer Causes & Control, Annals of Oncology and Cancer Prevention Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact